Studien | Der Arzneimittelbrief

AddHope2

The Effect of Liraglutide on the Treatment of Coronary Artery Disease and Type 2 Diabetes

Addiction 2014,

A randomised controlled trial, economic evaluation and qualitative study of supervised consumption in patients managed with opiate maintenance treatment

AdDIT

Adolescent Type 1 Diabetes Cardio-renal Intervention Trial

ADDITION

Anglo-Danish-Dutch study of Intensive Treatment In people with screen-detected diabetes in primary care

ADDITION-Cambridge

Anglo-Danish-Dutch study of Intensive Treatment In people with screen detected diabetes in primary care-Cambridge

ADDITION-Denmark

Anglo-Danish-Dutch study of Intensive Treatment In people with screen detected diabetes in primary care-Denmark

ADDITION-Europe

Anglo-Danish-Dutch study of Intensive Treatment In people with screen detected diabetes in primary care-Europe

ADDITION-Leicester

Anglo-Danish-Dutch study of Intensive Treatment In people with screen detected diabetes in primary care-Leicester

ADDRESS

ADministration of DRotrecogin alfa (activated) in Early stage Severe Sepsis study group

ADDRESS

Weight loss and treatment patterns in a real-world population of adults receiving liraglutide 3.0 mg for weight management in routine clinical practice in Switzerland

ADDRESS II

Long-term Safety and Tolerability of Atacicept

ADDUCE

Attention Deficit hyperactivity Disorder drugs Use Chronic Effects

ADEBAR

ADipositasprävention durch ein Ernährungs- und Bewegungsbasiertes FAmilienpRogramm

ADEBAR

Adjuvant Treatment of Breast Cancer Patients With Extensive Lymph Node Involvement

ADEG

Antiarrhythmic Drug Evaluation Group study

ADEMEX

ADEquacy of peritoneal dialysis in MEXico

ADENO

ADenomyosis and its Effect on Neonatal and Obstetric outcomes

ADEP

Atherosclerotic Disease Evolution by Picotamide

ADEPT

A Digitally Enabled, Pharmacist service to detecT medicine harms in residential aged care

ADePT

A process for DEcision-making after Pilot and feasibility Trials

ADEPT

ADalimumab Effectiveness in Psoriatic Arthritis Trial

ADEPT

Airways Disease Endotyping for Personalized Therapeutics

ADERADHTA

Radiofrequency Ablation for Aldosterone-producting Adenoma in Patients With Primary Aldosteronism

ADEST

BivAlirudin and Drug-Eluting STents study

A Study to Assess the Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)

ADHERE

Acute Decompensated HEart failure national REgistry

ADHERE

Randomized Controlled Trial Comparing Renal Function in De Novo Kidney Transplant Recipients Receiving Prolonged-Release Tacrolimus Plus Mycophenolate Mofetil or Sirolimus

ADhere

Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis

ADHERE LM

Acute Decompensated Heart failure national REgistry Longitudinal Module

ADHERE TNT

Trinidadian cardiovascular medication adherence survey

ADHERE-EM

Acute Decompensated HEart failure national Registry-Emergency Module

ADHINCRA

Addressing Hypertension Care in Africa

AdHOC

The AdgeD in HOme Care project

ADHT

Amlodipine Diabetic Hypertension Efficacy Response Evaluation Trial

ADIRA

Anti-inflammatory Diet In Rheumatoid Arthritis

ADjoin

Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis

ADJUNCT ONE

The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes

ADJUNCT TWO

The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes

ADJUST

Adalimumab in JIA-associated Uveitis Stopping Trial

ADJUST-PE

Age-adjusted D-dimer Cut-off Levels to Rule Out Pulmonary Embolism

ADJUVANT

The Unique Spatial-Temporal Treatment Failure Patterns of Adjuvant Gefitinib Therapy

ADJUVANT/CTONG1104

Gefitinib Versus Vinorelbine/Platinum as Adjuvant Treatment in Stage II-IIIA(N1-N2) NSCLC With EGFR Mutation

ADMEC-O

Adjuvant Therapy of Completely Resected Merkel Cell Carcinoma With Immune Checkpoint Blocking Antibodies vs Observation

ADMIRAL

A Study of ASP2215 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase (FLT3) Mutation

ADMIRAL

Abciximab before Direct angioplasty and stenting in Myocardial Infarction Regarding Acute and Long-term followup

ADMIRAL

Advanced Modeled Iterative Reconstruction

ADMIRAL

Assessing Donor-derived cell-free DNA Monitoring Insights of kidney Allografts with Longitudinal surveillance

AdmIRE

Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the BWI IRE Ablation System

ADMIRE

Results of the randomized phase IIB ADMIRE trial of FCR with or without mitoxantrone in previously untreated CLL

ADMIRE-CD

Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease

ADMIRE-HF

AdreView Myocardial Imaging for Risk Evaluation in Heart Failure

ADMISSIONREA

Predictors of Intensive Care Unit Refusal in French Intensive Care Units

ADMIT

Arterial Disease Multiple Intervention Trial

ADNI

Alzheimer's Disease Neuroimaging Initiative (1)

ADNI

Alzheimer's Disease Neuroimaging Initiative (2)

ADNI

Alzheimer's Disease Neuroimaging Initiative (3)